Beximco Pharmaceuticals Limited announced earnings results for the second quarter ended December 31, 2019. For the second quarter, the company announced sales was BDT 6,192.191 million compared to BDT 5,724.672 million a year ago. Operating income was BDT 1,324.358 million compared to BDT 1,254.937 million a year ago. Net income was BDT 861.686 million compared to BDT 733.472 million a year ago. Basic earnings per share was BDT 2.12 compared to BDT 1.81 a year ago. For the half year, sales was BDT 12,495.526 million compared to BDT 11,109.798 million a year ago. Operating income was BDT 2,757.894 million compared to BDT 2,485.143 million a year ago. Net income was BDT 1,726.446 million compared to BDT 1,488.403 million a year ago. Basic earnings per share was BDT 4.26 compared to BDT 3.67 a year ago.